{"transactions":[{"id":1637648,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":80000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637647,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.15,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637646,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":75000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637645,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested on January 22, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637644,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":60000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637643,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in three equal installments on October 26, 2021, October 26, 2022 and October 26, 2023."}],"balance_after":0,"derivative":{"exercise_price":8.58,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637642,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":60000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637641,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in three equal installments on January 7, 2019, January 7, 2020 and January 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":2130866,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase shares of common stock","published_at":"2022-10-27T20:51:40.000Z","date":"2022-10-18","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests ratably over three years commencing on October 18, 2023."}],"balance_after":80000,"derivative":{"exercise_price":2.15,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001731122-22-001810","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222001810/ownership.xml","form_type":"4"}},{"id":2201721,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase shares of common stock","published_at":"2022-07-26T23:02:30.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued in connection with the Company's employee retention plan."}],"balance_after":75000,"derivative":{"exercise_price":2.38,"exercise_date":"2023-01-20","expiration_date":"2032-07-20","underlying":"Common stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001731122-22-001245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222001245/ownership.xml","form_type":"4"}},{"id":2437473,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-11T22:54:29.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":16266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Ms. Puche received restricted stock units under the Issuer's 2019 Equity Incentive Plan. 11,266 of the restricted stock units vested on the Grant Date; the remaining 5,000 restricted stock units vested on January 7, 2022. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":16266,"source":{"system":"sec-edgar","filing":"0001731122-22-000044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222000044/ownership.xml","form_type":"4/A","original_submission_date":"2021-12-20"}},{"id":2437472,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-11T22:54:29.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer cancelled the shares of common stock previously issued to Ms. Puche upon the vesting of certain restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001731122-22-000044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222000044/ownership.xml","form_type":"4/A","original_submission_date":"2021-12-20"}},{"id":2463571,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-21T00:01:27.000Z","date":"2019-06-09","kind":"other","acquired":false,"shares":15000,"price":6.15,"value":92250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects the decision of the Enochian BioSciences Inc. board of directors to void and rescind, nunc pro tunc, the grant of 15,000 RSUs previously approved on June 9, 2019, under the Issuer's 2019 Equity Incentive Plan. As of the date of this Form 4, 10,000 RSUs had vested; the reporting person has agreed to surrender the 10,000 shares of common stock underlying the RSUs to Enochian BioSciences Inc. for cancellation."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001731122-21-002163","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112221002163/ownership.xml","form_type":"4"}},{"id":2463570,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-21T00:01:27.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":16266,"price":7.75,"value":126061.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Enochian Biosciences Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units under the Enochian BioSciences Inc. 2019 Equity Incentive Plan. 11,266 of the restricted stock units shall vest on the Grant Date; the remaining 5,000 restricted stock units shall vest on January 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":16266,"derivative":{"exercise_price":7.75,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":16266},"source":{"system":"sec-edgar","filing":"0001731122-21-002163","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112221002163/ownership.xml","form_type":"4"}},{"id":2497212,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase shares of common stock","published_at":"2021-11-23T17:41:59.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on October 26, 2022, October 26, 2023 and October 26, 2024."}],"balance_after":60000,"derivative":{"exercise_price":8.58,"expiration_date":"2031-10-26","underlying":"Common stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-21-002049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112221002049/ownership.xml","form_type":"4"}},{"id":3314335,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-10T02:28:10.000Z","date":"2020-01-07","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":0,"exercise_date":"2020-01-07","expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001731122-20-000033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112220000033/ownership.xml","form_type":"4"}},{"id":3314334,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-10T02:28:10.000Z","date":"2020-01-07","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001731122-20-000033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112220000033/ownership.xml","form_type":"4"}},{"id":3480978,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-06-21T20:36:41.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":15000,"price":6.15,"value":92250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 6, 2019, Ms. Puche was granted fifteen thousand (15,000) restricted stock units, vesting in equal amounts annually over three years from January 7, 2019, the date of her appointment as Chief Financial Officer of Enochian Biosciences, Inc."}],"balance_after":15000,"derivative":{"exercise_price":6.15,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001731122-19-000353","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112219000353/ownership.xml","form_type":"4"}},{"id":3480977,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-06-21T20:36:41.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":60000,"price":6.15,"value":369000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 6, 2019, Ms. Puche was granted options to purchase sixty thousand (60,000) shares of the Company's common stock vesting in equal amounts annually over three years from January 7, 2019, the date of her appointment as Chief Financial Officer of Enochian Biosciences, Inc., pursuant to the Company's 2014 Equity Incentive Plan."}],"balance_after":60000,"derivative":{"exercise_price":6.15,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-19-000353","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112219000353/ownership.xml","form_type":"4"}}]}